Please assess the completion status of the following clinical trial:

Trial Title: Safety and Tolerance of the Use of InnoCath AB® Hyper-compliant Balloon

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* 18 years of age~* Patients with peripheral arterial occlusive disease and intended for endovascular therapy in the SFA and/or popliteal artery pars I/II~* Patients suitable for endovascular therapy in the SFA and/or popliteal artery pars I/II with a hyper-compliant balloon without further luminal widening~* Target vessels with a sufficient runoff to the foot with at least one vessel~* Rutherford classification 1-4 if physical and medicinal therapies have not been successful~Exclusion Criteria:~* Aneurysms at the site of inflation~* Application directly in the area of large vessel wall injuries with heavy bleeding~* Rutherford classification 5 and 6

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- InnoCath AB® Balloon (Type: EXPERIMENTAL): endovascular treatment of lesions in the superficial femoral artery (SFA) and/or popliteal artery pars I/II without further luminal widening, and/or for short-term interruption of blood flow with the InnoCath AB® hyper-compliant balloon cathe-ters (100 or 200 mm length)

Based on this trial design, predict the completion outcome and termination type (if applicable).